Fresenius Medical Care AG / DE0005785802

Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from October 13, 2025 to October 17, 2025 (each inclusive), 338,754 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
15 October 2025	1,361	46.0038	62,611.14	AQEU
15 October 2025	67,022	46.0738	3,087,959.99	CEUX
15 October 2025	120,000	46.1021	5,532,256.58	XETA
16 October 2025	19,620	45.9247	901,042.45	CEUX
16 October 2025	96,251	46.0487	4,432,232.44	XETA
17 October 2025	34,500	46.4876	1,603,820.93	XETA

A total of 3,915,008 shares have been acquired within the framework of this share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.